According to the Patient Protection and Affordable Care Act, starting this year, Medicare and Medicaid will no longer charge copayments for proven preventive screenings such as CRC screenings. Medicare will also waive the deductible for CRC screenings regardless of whether a polyp or lesion is found. However, the copayment is not waived when a screening colonoscopy becomes therapeutic, and AGA has been aggressively lobbying to change this stipulation.
“The AGA encourages the Department of Health and Human Services to adhere to professional society guidelines on colorectal cancer screening to ensure that insurers do not limit patient access to various screening modalities,” said Ian L. Taylor, MD, president of the AGA Institute. “Both public and private health insurers should be required to cover all recommended options for screening for everyone age 50 years and older, or 45 years and older for those at higher risk, with reasonable copayment.”
Read the AGA news release about access for colorectal cancer screening.
Read other coverage about colorectal cancer screening:
– Study: GoLytely More Effective Bowel Prep Than MiraLAX
– Researchers Say Colonoscopy Needs More Widespread Use
– ASC, ASGE React to NYTimes ‘Letter’ About Colonoscopy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
